Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern
Stock Information for Interpace Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.